TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07589023: A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis

Sponsor: Globus Medical Inc · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 100 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07589023 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07589023 Rescue Dossier →